These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 2212824)
1. [Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma]. Ohwada M; Suzuki M; Tamada T Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1237-43. PubMed ID: 2212824 [TBL] [Abstract][Full Text] [Related]
2. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
3. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium. Onuma K; Dabbs DJ; Bhargava R Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321 [TBL] [Abstract][Full Text] [Related]
4. Affinity of four lectins for endocervical and endometrial non-neoplastic and neoplastic glandular epithelium. Toda T; Sadi AM; Egawa H; Atari E; Qureshi B; Nagai Y Histopathology; 1998 Mar; 32(3):257-63. PubMed ID: 9568512 [TBL] [Abstract][Full Text] [Related]
5. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus. Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419 [TBL] [Abstract][Full Text] [Related]
7. [Serum CA125 and CA19-9 levels in adenocarcinoma of the uterine cervix and endometrial carcinoma]. Ihara Y; Shimizu T; Kawaguchi K; Yomura W; Fujiwara T; Inoue K Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1711-8. PubMed ID: 3235884 [TBL] [Abstract][Full Text] [Related]
8. Endocervical-type epithelium in endometrial carcinoma: a report of 10 cases with emphasis on histochemical methods for differential diagnosis. Czernobilsky B; Katz Z; Lancet M; Gaton E Am J Surg Pathol; 1980 Oct; 4(5):481-9. PubMed ID: 7435776 [TBL] [Abstract][Full Text] [Related]
9. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614 [TBL] [Abstract][Full Text] [Related]
11. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia. Umezaki K; Sanezumi M; Okada H; Okamura A; Tsubra A; Kanazaki H Gynecol Oncol; 1997 Sep; 66(3):393-8. PubMed ID: 9299251 [TBL] [Abstract][Full Text] [Related]
12. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical identification of Langerhans cells in normal epithelium and in epithelial lesions of the uterine cervix. Puts JJ; Moesker O; de Waal RM; Kenemans P; Vooijs GP; Ramaekers FC Int J Gynecol Pathol; 1986; 5(2):151-62. PubMed ID: 3087896 [TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining. Mikami Y; Kiyokawa T; Moriya T; Sasano H Histopathology; 2005 Feb; 46(2):130-6. PubMed ID: 15693884 [TBL] [Abstract][Full Text] [Related]
15. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Jaworski RC Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of carcinoembryonic antigen in adenocarcinoma of the endocervix and the endometrium. Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M Tohoku J Exp Med; 1985 May; 146(1):27-32. PubMed ID: 3895576 [TBL] [Abstract][Full Text] [Related]
17. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124 [TBL] [Abstract][Full Text] [Related]
18. Expression of human kallikrein 7 (hK7/SCCE) and its inhibitor antileukoprotease (ALP/SLPI) in uterine endocervical glands and in cervical adenocarcinomas. Tian X; Shigemasa K; Hirata E; Gu L; Uebaba Y; Nagai N; O'Brien TJ; Ohama K Oncol Rep; 2004 Nov; 12(5):1001-6. PubMed ID: 15492784 [TBL] [Abstract][Full Text] [Related]
19. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma. Zaino RJ; Kurman RJ Semin Diagn Pathol; 1988 May; 5(2):154-71. PubMed ID: 3041509 [TBL] [Abstract][Full Text] [Related]
20. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. McCluggage WG; Sumathi VP; McBride HA; Patterson A Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]